公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2002 | Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; DING-SHINN CHEN | Journal of Clinical Microbiology | 142 | 138 | |
2022 | Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study) | Hirode, Grishma; Choi, Hannah S J; Chen, Chien-Hung; TUNG-HUNG SU ; Seto, Wai-Kay; Van Hees, Stijn; Papatheodoridi, Margarita; Lens, Sabela; Wong, Grace; Brakenhoff, Sylvia M; Chien, Rong-Nan; Feld, Jordan; Sonneveld, Milan J; Chan, Henry L Y; Forns, Xavier; Papatheodoridis, George V; Vanwolleghem, Thomas; Yuen, Man-Fung; Hsu, Yao-Chun; JIA-HORNG KAO ; Cornberg, Markus; Hansen, Bettina E; Jeng, Wen-Juei; Janssen, Harry L A | Gastroenterology | 63 | 44 | |
2015 | On-treatment low serum HBV RNA level predicts initial virological response in chronic hepatitis B patients receiving nucleoside analogue therapy | YI-WEN HUANG ; Takahashi S.; Tsuge M.; CHI-LING CHEN ; Wang T.-C.; Abe H.; Hu J.-T.; DING-SHINN CHEN ; Yang S.-S.; Chayama K.; JIA-HORNG KAO | Antiviral Therapy | 61 | 57 | |
2021 | One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment | TAI-CHUNG TSENG ; Choi J.; Nguyen M.H.; Peng C.-Y.; Siakavellas S.; Papatheodoridis G.; Wang C.-C.; Lim Y.-S.; Lai H.-C.; Trinh H.N.; Wong C.; Wong C.; Zhang J.; Li J.; JIA-HORNG KAO | Hepatology International | 5 | 7 | |
2018 | One-year weight management lowers lipopolysaccharide-binding protein and its implication in metainflammation and liver fibrosis | Nien H.-C.; JIN-CHUAN SHEU ; Chi Y.-C.; CHI-LING CHEN ; JIA-HORNG KAO ; WEI-SHIUNG YANG | PLoS ONE | 7 | 6 | |
2020 | An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients with Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistance-Associated Substitutions | Huang C.-F.; Hung C.-H.; Cheng P.-N.; Bair M.-J.; Huang Y.-H.; JIA-HORNG KAO ; SHIH-JER HSU ; Lee P.-L.; Chen J.-J.; Chien R.-N.; Peng C.-Y.; Lin C.-Y.; Hsieh T.-Y.; Cheng C.-H.; Dai C.-Y.; Huang J.-F.; Chuang W.-L.; Yu M.-L. | Journal of Infectious Diseases | 15 | 11 | |
2010 | Optimal management of hepatocellular carcinoma: Challenges and opportunities | Lin C.-L.; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 8 | 5 | |
2023 | Optimizing Survival Benefit by Surgical Resection by the Seven-Eleven Criteria in Barcelona Clinic Liver Cancer Stage A/B Hepatocellular Carcinoma beyond the Milan Criteria | Huang, Chian Tzu; Chu, Yu Long; TUNG-HUNG SU ; SHANG-CHIN HUANG ; TAI-CHUNG TSENG ; SHIH-JER HSU ; SIH-HAN LIAO ; CHUN-MING HONG ; CHEN-HUA LIU ; HUNG-CHIH YANG ; CHUN-JEN LIU ; PEI-JER CHEN ; JIA-HORNG KAO | Liver Cancer | | | |
2004 | Origin of serum hepatitis B virus in acute exacerbation: Comparison with HBV in the liver and from other exacerbation | CHUN-JEN LIU ; JIA-HORNG KAO ; HURNG-YI WANG ; Lai M.-Y.; Chen T.-C.; PEI-JER CHEN ; DING-SHINN CHEN | Hepatology | 17 | 17 | |
2010 | Outcomes of HCV treatment: Who does well and who does not? | Hsu C.-S.; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 1 | 1 | |
2023 | Outlook of future landscape of artificial intelligence in health care of liver disease and challenges | TUNG-HUNG SU ; JIA-HORNG KAO | Artificial Intelligence, Machine Learning, and Deep Learning in Precision Medicine in Liver Diseases: Concept, Technology, Application and Perspectives | | | |
2006 | Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants | CHUN-JEN LIU ; JIA-HORNG KAO ; PEI-JER CHEN ; Chen T.-C.; Lin F.-Y.; Lai M.-Y.; DING-SHINN CHEN | Journal of Viral Hepatitis | 14 | 12 | |
2022 | Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5 | CHEN-HUA LIU ; JIA-HORNG KAO | Hepatology International | 7 | 8 | |
2022 | Paradigm shift in the treatment options of hepatocellular carcinoma | TUNG-HUNG SU ; SHIH-JER HSU ; JIA-HORNG KAO | Liver international : official journal of the International Association for the Study of the Liver | 22 | 18 | |
2002 | Paratyphoid hepatitis: An emerging clinical entity [5] | PO-REN HSUEH ; JIA-HORNG KAO ; YEE-CHUN CHEN ; PAN-CHYR YANG ; KWEN-TAY LUH ; Wang T.-K.; Lin S.-F. | American Journal of Medicine | 7 | 5 | |
2019 | Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis | CHEN-HUA LIU ; Shih Y.-L; Yang S.-S; Lin C.-L; YU-JEN FANG ; Cheng P.-N; Chen C.-Y; Peng C.-Y; Hsieh T.-Y; Chiu Y.-C; TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 7 | 7 | |
2020 | Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan | Su H.-J.; JIA-HORNG KAO ; TAI-CHUNG TSENG ; HUNG-CHIH YANG ; TUNG-HUNG SU ; PEI-JER CHEN ; CHUN-JEN LIU | Journal of the Formosan Medical Association | 17 | 12 | |
2019 | Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: A systematic review and meta-analysis of individual participant data | Pavlovic V.; Yang L.; Chan H.L.-Y.; Hou J.; Janssen H.L.; JIA-HORNG KAO ; Lampertico P.; Peng C.-Y.; Piratvisuth T.; Thompson A.J.; Wedemeyer H.; Wei L.; Wat C. | Antiviral Therapy | 10 | 7 | |
2007 | Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV [6] | CHEN-HUA LIU ; DING-SHINN CHEN ; JIA-HORNG KAO | New England Journal of Medicine | 1 | 1 | |
2009 | Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses | CHUN-JEN LIU ; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; CHI-LING CHEN ; Kuo H.; Chao Y.; Tung S.; Yang S.; JIA-HORNG KAO ; CHEN-HUA LIU ; Su W.; Lin C.; YUNG-MING JENG ; PEI-JER CHEN ; DING-SHINN CHEN | Gastroenterology | 182 | 157 | |